Maynard Um
-
-
-
-
-
-
-
PMGC Holdings fully utilizes $20M equity financing facility
-
-
-
-
-
-
-
PMGC Holdings acquires stake in micro nuclear reactor developer
-
-
-
-
-
-
-
PMGC Holdings raises $1.67 million through warrant exercise agreement
-
-
-
-
-
-
-
Northstrive Biosciences (ELAB) Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 with GLP-1 Receptor Agonist for Obesity Treatment
-
-
-
-
-
-
-
PMGC Holdings (ELAB) Files $100M Mixed Shelf
-
-
-
-
-
-
-
Elevai (ELAB) Engages Leading Contract Research Organization to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
-
-
-
-
-
-
-
Elevai Labs (ELAB) Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology
-
401,060 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

